Study the feasibility of offering in vitro fertilization and other fertility treatment services across its network

Summary#

Res. 0111-2026 is a resolution, not a proposed local law. It calls on the NYC Health + Hospitals Corporation (H+H) to study whether it is feasible to offer IVF and other fertility treatments across its network; it would not require H+H to offer them. Prime sponsor: Frank Morano. The resolution was introduced and referred to committee on January 29, 2026, and is waiting in that committee.

  • The Council’s request is for a feasibility study, not a new treatment program or a change to city law.
  • The resolution does not set a deadline or specify what the study must cover.

What it means for you#

  • People seeking fertility care: The resolution does not give anyone a right to IVF or other treatment through H+H, and it does not change who is eligible for existing services.
  • H+H: The resolution calls on the corporation to study the feasibility of offering these services. It does not require H+H to expand services, choose locations, or partner with private clinics.
  • New Yorkers generally: The resolution does not create a fee, benefit, or new public service.

Money#

The resolution gives no estimate for the cost of conducting the study or offering fertility services.

  • The resolution’s sponsors cite an estimated $15,000 to $20,000 for one IVF cycle, and say a donor egg can raise the cost above $30,000. Those figures are not estimates of city spending.

What is unclear#

  • The resolution sets no deadline, reporting requirement, or public release requirement for the study.
  • It does not say what costs, locations, treatments, or patient groups the study should assess.
  • It does not say how H+H would decide whether to offer services or how any services would be funded.

Case for#

  • The resolution’s sponsors say the high cost of fertility treatment limits access, especially for people with low incomes or limited insurance coverage.
  • The sponsors point to H+H’s existing women’s health and obstetric services, and to a fertility clinic at Bellevue Hospital, as reasons to study whether services could be expanded.
  • The sponsors say a public option could serve groups they identify as facing barriers to private care, including LGBTQ+ people, single parents by choice, and cancer patients seeking fertility preservation.

Case against#

  • The resolution asks for a study only. Even if passed, it would not require H+H to offer or expand fertility treatment.
  • It gives no deadline or requirements for the study, so the Council’s request does not ensure when the findings would be available or what questions they would answer.